European Archives - Page 767 of 899 - European Medical Journal

Continue
14th June 2016

EAN 2016 – Prof Mads Henrik Ravnborg

Prof Mads Henrik Ravnborg’s press conference at EAN 2016. EMJ Neurology 4.1 2016 coming soon, subscribe for free today!
14th June 2016

EAN 2016 – Prof Franz Fazekas

Prof Franz Fazekas’s press conference at EAN 2016. EMJ Neurology 4.1 2016 coming soon, subscribe for free today!
14th June 2016

EAN 2016 – Prof Gunhild Waldemar

Prof Gunhild Waldemar’s press conference at EAN 2016. EMJ Neurology 4.1 2016 coming soon, subscribe for free today!
EMJ
14th June 2016

Overview of ZPL-3893787 (ZPL-389) clinical trial for atopic dermatitis

Thomas Werfel, MD, from Hannover Medical School, Hannover, Germany, gives an overview of a phase 2a proof-of-concept clinical trial evaluating ZPL…
EMJ
14th June 2016

Phase 2a trial of ZPL-3893787 (ZPL-389), a histamine H4 receptor antagonist, for atopic dermatitis

Thomas Werfel, MD, from Hannover Medical School, Hannover, Germany, discusses the design and outcomes from a phase 2a proof-of-concept clinical trial…
14th June 2016

Innovation in Education – EAU 2016

Don’t miss our congress review in our EMJ Urology 4.1 2016 eJournal, available now…
EMJ
14th June 2016

Translating genomics to precision medicine for breast cancer care: Ongoing clinical studies

At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Oleg Gluz, MD, from the West German…
EMJ
14th June 2016

Identifying breast cancer patients who can be spared chemotherapy, evidence from recent studies

The Oncotype DX® 21-gene Recurrence Score® result stratifies patients with breast cancer into low-, intermediate- and high-risk groups that correspond to…
EMJ
14th June 2016

Impact of phase 3 PlanB trial on evidence-based clinical practice for breast cancer

At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Oleg Gluz, MD, from the West German…
EMJ
14th June 2016

5-year outcomes from PlanB: Phase 3 trial of 21-gene Recurrence Score® result in breast cancer

At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Oleg Gluz, MD, from the West German…